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Kowalik and Jensen (1) have reported that intra-host variation in HCMV approaches levels similar to 
those of HCV, with fast mutation rates mooted as one explanation (2).While we discussed that HCMV 
mutation rates were postulated as an explanation for high diversity, the focus of our work is on 
observed inconsistencies in nucleotide diversity between and within patients (3). Kowalik and Jensen did 
calculate HCMV mutation rates to be similar to MCMV but maintained that this could underestimate the 
true levels (2).   In contrast, our study showed that in the absence of mixed infections, HCMV is no more 
diverse than other DNA viruses, and considerably less so than chronic RNA viruses.  This simple 
conclusion is different to that of Kowalik and Jensen and had not been stated prior to our publication.    
Their previous work concluded that diversity was similar in mixed and single HCMV infections and 
correlated with selection (4).  Yet in the presence of pervasive recombination or mixed infection, 
calculation of selection is unreliable and likely to be upwardly biased. Their use of consensus sequence 
principle component analysis (PCA) to identify mixed and single infections is also not optimal. PCA 
clusters by polymorphisms, ignoring haplotypes, and thus identifies mixed infections only where the 
constituent viruses are highly divergent, under-estimating their true number. We did not cite their work 
as we did not have the space to adequately discuss the discrepancies in our approaches.    
We agree that HCMV compartmentalization can exist eg. within the vitreous humor of the eye (5). 
However, our analyses were conducted on HCMV from blood where Kowalik and Jensen argue diversity 
is highest, so it is unlikely that our lower diversity estimates were an artefact of compartmentalization 
(6). Kowalik and Jensen also mention the importance of bottlenecks in generating diversity, arguing that 
severe bottlenecks can both decrease (1,5) and increase (2) diversity depending on the environment. 
Where we observe high diversity, we detect both haplotypes from the earliest timepoint, indicating that 
the initial infection bottleneck had already occurred. We agree that recombination renders phylogenetic 
(and indeed selection) analyses inaccurate. The RL11 region has the advantage of being in stronger 
linkage disequilibrium (7) and thus less affected by recombination. Notwithstanding, Figure 4 in our 
paper clearly demonstrates that the pairwise differences we detected between haplotypes is not limited 
to the RL11D region but extends to multiple regions across the genome (3).  
To summarize, Kowalik and Jensen postulate multiple complex models, which have themselves evolved 
over the years, to explain HCMV intrahost diversity (4, 6, 8). In contrast, we observe the measure of 
HCMV intrahost diversity can be explained by mixed infections involving genetically distant viral strains. 
We do not exclude the contribution of mutation or recombination to HCMV evolution over short or 
longer periods in our PNAS paper (3) or in our previous publications (7, 9).  Importantly, our methods 
can be applied to other pathogens and our conclusions for HCMV are now supported by the findings of 
other leaders in the field of HCMV genetics (5, 10). 
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